Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$3,272.00
Sep 19, 2025
For-profit organization
CIIP PDA – Cytophage Technologies Inc. – 2025-26
7471000 P016993001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$3,247.00
Sep 19, 2025
For-profit organization
CIIP PDA – Eyam Health Inc. – 2025-26
7471002 P017016001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$3,167.00
Sep 19, 2025
For-profit organization
CIIP PDA – iProgen Biotech Inc. – 2025-26
7471003 P017017001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$3,526.00
Sep 19, 2025
For-profit organization
CIIP PDA – Catalyze AI Inc. – 2025-26
7471007 P017018001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$5,949.00
Sep 19, 2025
For-profit organization
CIIP PDA – iClinic Systems Inc. – 2025-26
7471263 P017044001
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$80,742.42
Sep 19, 2025
Aboriginal recipient
ISCF-187.1 - CLFN - TORs and Work Plan Activities 2025
9100016327
The purpose of this funding is to support Curve Lake Fisrt Nation in participating in activities related to their Terms of Reference and workplan for the 2025 calendar year.
$73,032.25
Sep 19, 2025
Aboriginal recipient
ISCF-196.1 - HFN - TORs and Work Plan Activities 2025
9100016554
The purpose of this funding is to support Hiawatha First Nation in participating in activities related to their Terms of Reference for long-term engagement and workplan activities for 2025.
$500,000.00
Sep 19, 2025
For-profit organization
227904
227904
Support cash flow requirements for the execution of a major contract
$74,700.00
Sep 19, 2025
Academia
Polaris neocytolysis assessed by mining blood and air samples (Polestar)
25HLSDM1
The Polestar payload aims to address outstanding questions on the mechanism of space anemia. Polestar will test three key hypotheses: 1. Older red blood cells (RBC) are preferentially destroyed in space; 2. Space can induce a shift from adult to fetal hemoglobin; and 3. Space induces RBC morphological changes, causing RBC dysfunction. Using blood and air samples collected from the SpaceX Polaris Dawn five-day mission, Polestar will measure the effect of high-altitude space and space radiation on space hemolysis in four astronauts compared to four age-related and sex-matched ground controls. Polestar will investigate the subpopulation of hemolyzed RBCs, hemoglobin gene-switching, and RBC anomalies, using state-of-the-art methods often applied for the first time to space samples. Polestar leverages private space missions to speed up critical space life science advances.
$17,100.00
Sep 19, 2025
Aboriginal recipient
Support aboriginal communities in becoming successful participants in commercial fisheries and aquaculture